Sort
8,912 grants matching “sars cov 2”
Comparison of RAS inhibitor classes for cerebrovascular management in hypertensive patients who contracted COVID-19 infection
$462,000David H Salat · Massachusetts General Hospital · R21 · FY2021 · AG
Crossing scales to predict and prevent bat virus zoonoses in a Madagascar ecosystem
$461,856Cara Brook · University Of Chicago · DP2 · FY2023 · AI
Computational Chemistry and Macromolecular Modeling
$461,744William Copeland · National Institute Of Environmental Health Sciences · ZIC · FY2022 · ES
Lentivirus Replication Strategy and Pathogenesis
$461,675Baek Kim · Emory University · R01 · FY2023 · AI
Community Developed Technology-Based Messaging to Increase SARS-CoV-2 Vaccine Uptake Among People Who Inject Drugs
$461,653Ian David Aronson · Ndri-Usa, Inc. · R01 · FY2024 · DA
Biostatistics Core
$461,508Meredith Nahm Zozus · University Of Texas Hlth Science Center · U19 · FY2024 · AG
Nanopore Methods for Determining Capsid Viability
$461,132Kimberly Ritola · Univ Of North Carolina Chapel Hill · R01 · FY2022 · FD
SARS-CoV-2 Virology Core
$461,091Gunjan Arora · National Institute Of Allergy And Infectious Diseases · ZIC · FY2025 · AI
HOPE Training Grant
$461,039Scott L Letendre · University Of California, San Diego · T32 · FY2023 · AI
Manipulating nucleic acids: applications in RNA biosensing, single-molecule analysis, and DNA nanotechnology
$460,856Ken A Halvorsen · State University Of New York At Albany · R35 · FY2022 · GM
The Johns Hopkins Baltimore-Washington-India Clinical Trials Unit (BWI CTU)
$460,679Charles W. Flexner · Johns Hopkins University · UM1 · FY2020 · AI
COVID-19 Administrative Supplement for FOXO3 Genotype, InflammAging, Cardiovascular Disease, and Dementia. Kuakini Hawaii Lifespan Study III
$460,652Bradley J Willcox · Kuakini Medical Center · R01 · FY2020 · AG
Platelet-MLKL role in S100 Release with Age and Infection
$460,625Milka Koupenova · Univ Of Massachusetts Med Sch Worcester · R21 · FY2025 · AG
Sympathetic-Vascular Dysfunction in Obesity-Related Hypertension
$460,624Seth William Holwerda · University Of Kansas Medical Center · R01 · FY2021 · HL
Crossing scales to predict and prevent bat virus zoonoses in a Madagascar ecosystem
$460,576Cara Brook · University Of Chicago · DP2 · FY2022 · AI
Unraveling the role of the CFTR ion channel in susceptibility to SARS-CoV-2 infection and inflammation
$460,500Amal O Amer · Ohio State University · R01 · FY2020 · AI
The Effects of Prior Checkpoint Inhibitor (CPI) Therapy on Mouse Hepatitis Coronavirus Induced Pneumonia
$460,497Parizad Torabi-Parizi · National Heart, Lung, And Blood Institute · ZIA · FY2024 · HL
dsRNA regulation of the cytosolic innate immune system
$460,018Graeme L Conn · Emory University · R01 · FY2023 · AI
dsRNA regulation of the cytosolic innate immune system
$460,018Graeme L Conn · Emory University · R01 · FY2024 · AI
dsRNA regulation of the cytosolic innate immune system
$460,018Graeme L Conn · Emory University · R01 · FY2025 · AI
Characterization of replication and transcription of SARS-CoV-2
$459,820Wei Yang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2023 · DK
DIGITAL HEALTH SOLUTIONS FOR COVID-19: COVIDSEEKER AND COVID-19 CITIZEN SCIENCE
$459,748Gregory Marcus · University Of California, San Francisco · N01 · FY2020 · CA
The KIDCOV Study: Assessment of Kidney Injury and Associated Risk Factors for SARS-CoV-2
$459,623Minnie M Sarwal · University Of California, San Francisco · R01 · FY2020 · DK
NOX1 and NOX2 as Therapeutic Targets in Influenza
$459,610J. David Lambeth · Emory University · R33 · FY2015 · AI
PROJECT 2: INNATE IMMUNITY
$459,575Rafi Ahmed · Emory University · U19 · FY2025 · AI